{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T18:00:03Z","timestamp":1785088803858,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,26]]},"DOI":"10.7759\/cureus.113404","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T17:23:07Z","timestamp":1785086587000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Multidrug-Resistant Infections in ICUs: A Narrative Review of Pharmacological and Non-pharmacological Interventions"],"prefix":"10.7759","author":[{"given":"Chetan","family":"Chandrashekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansiben","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herrieth","family":"Jandwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amardeepsinh","family":"Jadeja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya Kumar","family":"Javvaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, 18:268-281. 10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022, 399:629-655. 10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00118-5","article-title":"The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance","volume":"25","author":"Sati H","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, et al.. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis. 2025, 25:1033-1043. 10.1016\/S1473-3099(25)00118-5","journal-title":"Lancet Infect Dis"},{"key":"ref4","unstructured":"World Health Organization. Global antibiotic resistance surveillance report 2025: WHO global antimicrobial resistance and use surveillance system (GLASS) . (2025). Accessed: May 30, 2026: https:\/\/www.who.int\/."},{"key":"ref5","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. (2019). Accessed: May 30, 2026: https:\/\/stacks.cdc.gov\/view\/cdc\/82532."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13121130","article-title":"Unveiling the dynamics of antimicrobial resistance: a year-long surveillance at the largest infectious disease hospital in Western Romania","volume":"13","author":"Laitin SM","year":"2024","unstructured":"Laitin SM, Baditoiu LM, Laza R, et al.. Unveiling the dynamics of antimicrobial resistance: a year-long surveillance at the largest infectious disease hospital in Western Romania. Antibiotics (Basel). 2024, 13:1130. 10.3390\/antibiotics13121130","journal-title":"Antibiotics (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.slasd.2025.100232","article-title":"Antimicrobial resistance: linking molecular mechanisms to public health impact","volume":"33","author":"Muteeb G","year":"2025","unstructured":"Muteeb G, Kazi RN, Aatif M, Azhar A, Oirdi ME, Farhan M. Antimicrobial resistance: linking molecular mechanisms to public health impact. SLAS Discov. 2025, 33:100232. 10.1016\/j.slasd.2025.100232","journal-title":"SLAS Discov"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1039\/d5md00358j","article-title":"Harnessing biological insights to accelerate drug discovery against ESKAPE pathogens","volume":"17","author":"Palmo T","year":"2026","unstructured":"Palmo T, Jamwal V, Kumari D, Singh K. Harnessing biological insights to accelerate drug discovery against ESKAPE pathogens. RSC Med Chem. 2026, 17:132-162. 10.1039\/d5md00358j","journal-title":"RSC Med Chem"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics14111167","article-title":"Mechanisms and evolution of antimicrobial resistance in ophthalmology: surveillance, clinical implications, and future therapies","volume":"14","author":"Osei Duah Junior I","year":"2025","unstructured":"Osei Duah Junior I, Ampong J, Danquah CA. Mechanisms and evolution of antimicrobial resistance in ophthalmology: surveillance, clinical implications, and future therapies. Antibiotics (Basel). 2025, 14:1167. 10.3390\/antibiotics14111167","journal-title":"Antibiotics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41429-025-00860-5","article-title":"The mechanisms of antibiotic resistance and drug resistance transmission of Klebsiella pneumoniae","volume":"78","author":"Zheng S","year":"2025","unstructured":"Zheng S, Li S, Zhang D, et al.. The mechanisms of antibiotic resistance and drug resistance transmission of Klebsiella pneumoniae. J Antibiot (Tokyo). 2025, 78:704-716. 10.1038\/s41429-025-00860-5","journal-title":"J Antibiot (Tokyo)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1017\/S0195941700003829","article-title":"Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit","volume":"17","author":"Flaherty JP","year":"1996","unstructured":"Flaherty JP, Weinstein RA. Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol. 1996, 17:236-248. 10.1017\/S0195941700003829","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01558-w","article-title":"Antimicrobial stewardship in the intensive care unit: the role of biomarkers, pharmacokinetics, and pharmacodynamics","volume":"38","author":"Moniz P","year":"2021","unstructured":"Moniz P, Coelho L, P\u00f3voa P. Antimicrobial stewardship in the intensive care unit: the role of biomarkers, pharmacokinetics, and pharmacodynamics. Adv Ther. 2021, 38:164-179. 10.1007\/s12325-020-01558-w","journal-title":"Adv Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6905450","article-title":"What healthcare workers should know about environmental bacterial contamination in the intensive care unit","volume":"2017","author":"Russotto V","year":"2017","unstructured":"Russotto V, Cortegiani A, Fasciana T, et al.. What healthcare workers should know about environmental bacterial contamination in the intensive care unit. Biomed Res Int. 2017, 2017:6905450. 10.1155\/2017\/6905450","journal-title":"Biomed Res Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1696980","article-title":"Controlling the diffusion of multidrug-resistant organisms in intensive care units","volume":"40","author":"Kern\u00e9is S","year":"2019","unstructured":"Kern\u00e9is S, Lucet JC. Controlling the diffusion of multidrug-resistant organisms in intensive care units. Semin Respir Crit Care Med. 2019, 40:558-568. 10.1055\/s-0039-1696980","journal-title":"Semin Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.6832","article-title":"Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries","volume":"9","author":"Alp E","year":"2015","unstructured":"Alp E, Damani N. Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries. J Infect Dev Ctries. 2015, 9:1040-1045. 10.3855\/jidc.6832","journal-title":"J Infect Dev Ctries"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/amh70020014","article-title":"Influence of microbiome interactions on antibiotic resistance development in the ICU environment: insights and opportunities with machine learning","volume":"70","author":"Sakagianni A","year":"2025","unstructured":"Sakagianni A, Koufopoulou C, Koufopoulos P, et al.. Influence of microbiome interactions on antibiotic resistance development in the ICU environment: insights and opportunities with machine learning. Acta Microbiol Hell. 2025, 70:14. 10.3390\/amh70020014","journal-title":"Acta Microbiol Hell"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-4-200102200-00014","article-title":"Antibiotic resistance in the intensive care unit","volume":"134","author":"Kollef MH","year":"2001","unstructured":"Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001, 134:298-314. 10.7326\/0003-4819-134-4-200102200-00014","journal-title":"Ann Intern Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1275534","article-title":"Antibiotic stewardship in the intensive care unit","volume":"32","author":"Arnold HM","year":"2011","unstructured":"Arnold HM, Micek ST, Skrupky LP, Kollef MH. Antibiotic stewardship in the intensive care unit. Semin Respir Crit Care Med. 2011, 32:215-227. 10.1055\/s-0031-1275534","journal-title":"Semin Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","author":"Tamma PD","year":"2024","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections. Clin Infect Dis. 2024, ciae403. 10.1093\/cid\/ciae403","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00020-18","article-title":"Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology","volume":"31","author":"Lakhundi S","year":"2018","unstructured":"Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018, 31:e00020-18. 10.1128\/CMR.00020-18","journal-title":"Clin Microbiol Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul M","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, et al.. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022, 28:521-547. 10.1016\/j.cmi.2021.11.025","journal-title":"Clin Microbiol Infect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021, 49:e1063-e1143. 10.1097\/CCM.0000000000005337","journal-title":"Crit Care Med"},{"key":"ref23","article-title":"Antimicrobial stewardship","author":"Shrestha J","year":"2026","unstructured":"Shrestha J, Zahra F, Cannady J. Antimicrobial stewardship. StatPearls Publishing, Treasure Island, FL; 2026."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071401","article-title":"Optimizing antimicrobial drug dosing in critically ill patients","volume":"9","author":"P\u00f3voa P","year":"2021","unstructured":"P\u00f3voa P, Moniz P, Pereira JG, Coelho L. Optimizing antimicrobial drug dosing in critically ill patients. Microorganisms. 2021, 9:1401. 10.3390\/microorganisms9071401","journal-title":"Microorganisms"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu C","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, et al.. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011, 52:e18-e55. 10.1093\/cid\/ciq146","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches I","year":"2023","unstructured":"Martin-Loeches I, Torres A, Nagavci B, et al.. ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023, 49:615-632. 10.1007\/s00134-023-07033-8","journal-title":"Intensive Care Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.04.027","article-title":"Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper","volume":"26","author":"Turnidge J","year":"2020","unstructured":"Turnidge J, Kahlmeter G, Cant\u00f3n R, MacGowan A, Giske CG. Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper. Clin Microbiol Infect. 2020, 26:1039-1043. 10.1016\/j.cmi.2020.04.027","journal-title":"Clin Microbiol Infect"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0117-2023","article-title":"Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia","volume":"32","author":"Torres A","year":"2023","unstructured":"Torres A, Kuraieva A, Stone GG, Cill\u00f3niz C. Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia. Eur Respir Rev. 2023, 32:230117. 10.1183\/16000617.0117-2023","journal-title":"Eur Respir Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin D","year":"2018","unstructured":"van Duin D, Lok JJ, Earley M, et al.. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Clin Infect Dis. 2018, 66:163-171. 10.1093\/cid\/cix783","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0214-1","article-title":"Effect and safety of meropenem-vaborbactam versus best-available therapy in patients with carbapenem-resistant enterobacteriaceae infections: the tango ii randomized clinical trial","volume":"7","author":"Wunderink RG","year":"2018","unstructured":"Wunderink RG, Giamarellos-Bourboulis EJ, Rahav G, et al.. Effect and safety of meropenem-vaborbactam versus best-available therapy in patients with carbapenem-resistant enterobacteriaceae infections: the tango ii randomized clinical trial. Infect Dis Ther. 2018, 7:439-455. 10.1007\/s40121-018-0214-1","journal-title":"Infect Dis Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa878","article-title":"Imipenem-relebactam for treatment of carbapenem-resistant Gram-negative bacteria: Where do we stand on in vitro susceptibility testing?","volume":"72","author":"Sfeir MM","year":"2021","unstructured":"Sfeir MM. Imipenem-relebactam for treatment of carbapenem-resistant Gram-negative bacteria: Where do we stand on in vitro susceptibility testing?. Clin Infect Dis. 2021, 72:1484-1485. 10.1093\/cid\/ciaa878","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00194-23","article-title":"Cefiderocol treatment for patients with multidrug- and carbapenem-resistant pseudomonas aeruginosa infections in the compassionate use program","volume":"67","author":"Satlin MJ","year":"2023","unstructured":"Satlin MJ, Simner PJ, Slover CM, Yamano Y, Nagata TD, Portsmouth S. Cefiderocol treatment for patients with multidrug- and carbapenem-resistant pseudomonas aeruginosa infections in the compassionate use program. Antimicrob Agents Chemother. 2023, 67:e0019423. 10.1128\/aac.00194-23","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.88519","article-title":"How to defeat multidrug-resistant bacteria in intensive care units. A lesson from the covid-19 pandemic. prevention, reservoirs, and implications for clinical practiceal Practice","volume":"21","author":"Wo\u017aniak A","year":"2024","unstructured":"Wo\u017aniak A, Janc J, \u0141ysenko L, Le\u015bnik P, S\u0142abisz N, Oleksy-Wawrzyniak M, Uchmanowicz I. How to defeat multidrug-resistant bacteria in intensive care units. A lesson from the covid-19 pandemic. prevention, reservoirs, and implications for clinical practiceal Practice. Int J Med Sci. 2024, 21:530-539. 10.7150\/ijms.88519","journal-title":"Int J Med Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-025-02498-9","article-title":"Infection prevention and control measures for multidrug-resistant organisms: a systematic review and network meta-analysis","volume":"53","author":"Geng Y","year":"2025","unstructured":"Geng Y, Liu Z, Ma X, et al.. Infection prevention and control measures for multidrug-resistant organisms: a systematic review and network meta-analysis. Infection. 2025, 53:1789-1800. 10.1007\/s15010-025-02498-9","journal-title":"Infection"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1399067","article-title":"Uses of a real-time automatic nosocomial infection surveillance system to support prevention and control of hospital-acquired infections in the ICU","volume":"12","author":"Li X","year":"2024","unstructured":"Li X, Cai P, Zhong H, Yan C, Wen R. Uses of a real-time automatic nosocomial infection surveillance system to support prevention and control of hospital-acquired infections in the ICU. Front Public Health. 2024, 12:1399067. 10.3389\/fpubh.2024.1399067","journal-title":"Front Public Health"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1086\/650451","article-title":"Systematic review of studies on compliance with hand hygiene guidelines in hospital care","volume":"31","author":"Erasmus V","year":"2010","unstructured":"Erasmus V, Daha TJ, Brug H, Richardus JH, Behrendt MD, Vos MC, van Beeck EF. Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol. 2010, 31:283-294. 10.1086\/650451","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_20_129","article-title":"Role of surveillance cultures in infection control","volume":"38","author":"Biswal M","year":"2020","unstructured":"Biswal M, Angrup A, Kanaujia R. Role of surveillance cultures in infection control. Indian J Med Microbiol. 2020, 38:277-283. 10.4103\/ijmm.IJMM_20_129","journal-title":"Indian J Med Microbiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202002-181OC","article-title":"Predictive performance of risk factors for multidrug-resistant pathogens in nosocomial pneumonia","volume":"18","author":"Domined\u00f2 C","year":"2021","unstructured":"Domined\u00f2 C, Ceccato A, Niederman M, et al.. Predictive performance of risk factors for multidrug-resistant pathogens in nosocomial pneumonia. Ann Am Thorac Soc. 2021, 18:807-814. 10.1513\/AnnalsATS.202002-181OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa071","article-title":"Acquisition of antibiotic-resistant gram-negative bacteria in the benefits of universal glove and gown (bugg) cluster randomized trial","volume":"72","author":"Harris AD","year":"2021","unstructured":"Harris AD, Morgan DJ, Pineles L, Magder L, O'Hara LM, Johnson JK. Acquisition of antibiotic-resistant gram-negative bacteria in the benefits of universal glove and gown (bugg) cluster randomized trial. Clin Infect Dis. 2021, 72:431-437. 10.1093\/cid\/ciaa071","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(24)00399-2","article-title":"Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial","volume":"24","author":"Browne K","year":"2024","unstructured":"Browne K, White NM, Russo PL, et al.. Investigating the effect of enhanced cleaning and disinfection of shared medical equipment on health-care-associated infections in Australia (CLEEN): a stepped-wedge, cluster randomised, controlled trial. Lancet Infect Dis. 2024, 24:1347-1356. 10.1016\/S1473-3099(24)00399-2","journal-title":"Lancet Infect Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-026-02747-5","article-title":"Correction to: infection prevention and control measures for multidrug-resistant organisms: a systematic review and network meta-analysis","volume":"54","author":"Geng Y","year":"2026","unstructured":"Geng Y, Liu Z, Ma X, et al.. Correction to: infection prevention and control measures for multidrug-resistant organisms: a systematic review and network meta-analysis. Infection. 2026, 54:1033-1034. 10.1007\/s15010-026-02747-5","journal-title":"Infection"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2021.257","article-title":"The role of simulation-based training in healthcare-associated infection (HAI) prevention","volume":"2","author":"Kang M","year":"2022","unstructured":"Kang M, Nagaraj MB, Campbell KK, Nazareno IA, Scott DJ, Arocha D, Trivedi JB. The role of simulation-based training in healthcare-associated infection (HAI) prevention. Antimicrob Steward Healthc Epidemiol. 2022, 2:e20. 10.1017\/ash.2021.257","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000001313","article-title":"Update on infection prevention in the ICU","volume":"31","author":"Medioli F","year":"2025","unstructured":"Medioli F, Franceschini E, Mussini C, Meschiari M. Update on infection prevention in the ICU. Curr Opin Crit Care. 2025, 31:529-538. 10.1097\/MCC.0000000000001313","journal-title":"Curr Opin Crit Care"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-1641-9","article-title":"The challenge of antimicrobial resistance in intensive care setting","volume":"11","author":"Piscitelli P","year":"2025","unstructured":"Piscitelli P, Costigliola V, Azamfirei L. The challenge of antimicrobial resistance in intensive care setting. J Crit Care Med (Targu Mures). 2025, 11:109-111. 10.1007\/s00134-003-1641-9","journal-title":"J Crit Care Med (Targu Mures)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.glmedi.2024.100081","article-title":"Antimicrobial resistance: impacts, challenges, and future prospects","volume":"2","author":"Ahmed SK","year":"2024","unstructured":"Ahmed SK, Hussein S, Qurbani K, et al.. Antimicrobial resistance: impacts, challenges, and future prospects. J Med Surg Public Health. 2024, 2:100081. 10.1016\/j.glmedi.2024.100081","journal-title":"J Med Surg Public Health"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00993-0","article-title":"Alternative therapeutic strategies to treat antibiotic-resistant pathogens","volume":"22","author":"MacNair CR","year":"2024","unstructured":"MacNair CR, Rutherford ST, Tan MW. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nat Rev Microbiol. 2024, 22:262-275. 10.1038\/s41579-023-00993-0","journal-title":"Nat Rev Microbiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/puh2.70034","article-title":"Antibiotic resistance in developing countries: emerging threats and policy responses","volume":"4","author":"Ehsan H","year":"2025","unstructured":"Ehsan H. Antibiotic resistance in developing countries: emerging threats and policy responses. Public Health Chall. 2025, 4:e70034. 10.1002\/puh2.70034","journal-title":"Public Health Chall"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz6992","article-title":"Biology of antimicrobial resistance and approaches to combat it","volume":"12","author":"Schrader SM","year":"2020","unstructured":"Schrader SM, Vaubourgeix J, Nathan C. Biology of antimicrobial resistance and approaches to combat it. Sci Transl Med. 2020, 12:eaaz6992. 10.1126\/scitranslmed.aaz6992","journal-title":"Sci Transl Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13060502","article-title":"Implications of artificial intelligence in addressing antimicrobial resistance: innovations, global challenges, and healthcare\u2019s future","volume":"13","author":"Branda F","year":"2024","unstructured":"Branda F, Scarpa F. Implications of artificial intelligence in addressing antimicrobial resistance: innovations, global challenges, and healthcare\u2019s future. Antibiotics (Basel). 2024, 13:502. 10.3390\/antibiotics13060502","journal-title":"Antibiotics (Basel)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01082-24","article-title":"Genomics for antimicrobial resistance-progress and future directions","volume":"69","author":"Sherry NL","year":"2025","unstructured":"Sherry NL, Lee JY, Giulieri SG, et al.. Genomics for antimicrobial resistance-progress and future directions. Antimicrob Agents Chemother. 2025, 69:e0108224. 10.1128\/aac.01082-24","journal-title":"Antimicrob Agents Chemother"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.10.005","article-title":"Impact of vaccines on antimicrobial resistance","volume":"90","author":"Buchy P","year":"2020","unstructured":"Buchy P, Ascioglu S, Buisson Y, Datta S, Nissen M, Tambyah PA, Vong S. Impact of vaccines on antimicrobial resistance. Int J Infect Dis. 2020, 90:188-196. 10.1016\/j.ijid.2019.10.005","journal-title":"Int J Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06200-2","article-title":"Antimicrobial stewardship in the ICU: practical implementation","volume":"46","author":"De Waele JJ","year":"2020","unstructured":"De Waele JJ, Schouten J, Beovic B, et al.. Antimicrobial stewardship in the ICU: practical implementation. Intensive Care Med. 2020, 46:2367-2378. 10.1007\/s00134-020-06200-2","journal-title":"Intensive Care Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000000534","article-title":"Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant\/extensively drug-resistant\/pandrug-resistant bacteria","volume":"24","author":"Bassetti M","year":"2018","unstructured":"Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant\/extensively drug-resistant\/pandrug-resistant bacteria. Curr Opin Crit Care. 2018, 24:385-393. 10.1097\/MCC.0000000000000534","journal-title":"Curr Opin Crit Care"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2017.1367666","article-title":"Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art","volume":"15","author":"Maraolo AE","year":"2017","unstructured":"Maraolo AE, Cascella M, Corcione S, et al.. Management of multidrug-resistant Pseudomonas aeruginosa in the intensive care unit: state of the art. Expert Rev Anti Infect Ther. 2017, 15:861-871. 10.1080\/14787210.2017.1367666","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4682-7","article-title":"The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship","volume":"43","author":"Kollef MH","year":"2017","unstructured":"Kollef MH, Bassetti M, Francois B, et al.. The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Med. 2017, 43:1187-1197. 10.1007\/s00134-017-4682-7","journal-title":"Intensive Care Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2025.101561","article-title":"Optimization of antimicrobial therapy in critically ill patients, what clinicians and searchers must know","volume":"44","author":"Roger C","year":"2025","unstructured":"Roger C, Koulenti D, Novy E, Roberts J, Dahyot-Fizelier C. Optimization of antimicrobial therapy in critically ill patients, what clinicians and searchers must know. Anaesth Crit Care Pain Med. 2025, 44:101561. 10.1016\/j.accpm.2025.101561","journal-title":"Anaesth Crit Care Pain Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17070820","article-title":"Phage therapy in managing multidrug-resistant (mdr) infections in cancer therapy: innovations, complications, and future directions","volume":"17","author":"Mafe AN","year":"2025","unstructured":"Mafe AN, B\u00fcsselberg D. Phage therapy in managing multidrug-resistant (mdr) infections in cancer therapy: innovations, complications, and future directions. Pharmaceutics. 2025, 17:820. 10.3390\/pharmaceutics17070820","journal-title":"Pharmaceutics"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081255","article-title":"Preventing multidrug-resistant bacterial transmission in the intensive care unit with a comprehensive approach: a policymaking manual","volume":"12","author":"Schinas G","year":"2023","unstructured":"Schinas G, Polyzou E, Spernovasilis N, Gogos C, Dimopoulos G, Akinosoglou K. Preventing multidrug-resistant bacterial transmission in the intensive care unit with a comprehensive approach: a policymaking manual. Antibiotics (Basel). 2023, 12:1255. 10.3390\/antibiotics12081255","journal-title":"Antibiotics (Basel)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13111035","article-title":"An update on recent clinical trial data in bloodstream infection","volume":"13","author":"Stewart AG","year":"2024","unstructured":"Stewart AG, Simos P, Sivabalan P, Escol\u00e0-Verg\u00e9 L, Garnham K, Isler B. An update on recent clinical trial data in bloodstream infection. Antibiotics (Basel). 2024, 13:1035. 10.3390\/antibiotics13111035","journal-title":"Antibiotics (Basel)"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1740977","article-title":"Antimicrobial stewardship in ICU","volume":"43","author":"Murphy CV","year":"2022","unstructured":"Murphy CV, Reed EE, Herman DD, Magrum B, Beatty JJ, Stevenson KB. Antimicrobial stewardship in ICU. Semin Respir Crit Care Med. 2022, 43:131-140. 10.1055\/s-0041-1740977","journal-title":"Semin Respir Crit Care Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2017.1274232","article-title":"Antibiotic stewardship in community-acquired pneumonia","volume":"15","author":"Viasus D","year":"2017","unstructured":"Viasus D, Vecino-Moreno M, De La Hoz JM, Carratal\u00e0 J. Antibiotic stewardship in community-acquired pneumonia. Expert Rev Anti Infect Ther. 2017, 15:351-359. 10.1080\/14787210.2017.1274232","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03300-2020","article-title":"World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update","volume":"57","author":"Mirzayev F","year":"2021","unstructured":"Mirzayev F, Viney K, Linh NN, et al.. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J. 2021, 57:2003300. 10.1183\/13993003.03300-2020","journal-title":"Eur Respir J"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2018.58","article-title":"A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: the rise of multidrug-resistant Acinetobacter baumannii","volume":"39","author":"Teerawattanapong N","year":"2018","unstructured":"Teerawattanapong N, Panich P, Kulpokin D, et al.. A systematic review of the burden of multidrug-resistant healthcare-associated infections among intensive care unit patients in Southeast Asia: the rise of multidrug-resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2018, 39:525-533. 10.1017\/ice.2018.58","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/502529-management-of-multidrug-resistant-infections-in-icus-a-narrative-review-of-pharmacological-and-non-pharmacological-interventions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T17:23:09Z","timestamp":1785086589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/502529-management-of-multidrug-resistant-infections-in-icus-a-narrative-review-of-pharmacological-and-non-pharmacological-interventions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":63,"URL":"https:\/\/doi.org\/10.7759\/cureus.113404","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,26]]}}}